A Decentralized Study to Evaluate Physical Activity and Cough Frequency Using Wearable Technology in Cystic Fibrosis

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Cystic Fibrosis
Trial Locations (17)

10003

Mount Sinai Beth Israel, New York

15224

UPMC Children's Hospital of Pittsburgh, Pittsburgh

32803

Central Florida Pulmonary Group, P.A., Orlando

53792

UW School of Medicine & Public Health, Madison

61637

Children's Hospital of Illinois at OSF Saint Francis Medical Center, Cystic Fibrosis Center, Peoria

63110

Washington University School of Medicine, St Louis

73112

Santiago Reyes, M.D., Oklahoma City

80206

National Jewish Health, Denver

06510

Yale New Haven Hospital, New Haven

02114

Massachusetts General Hospital Cystic Fibrosis Center Clinical Rsearch Center, Boston

07960

Morristown Medical Center, Morristown

Unknown

Birmingham Heartlands Hospital, Birmingham

Royal Devon and Exeter Hospital, Exeter

St. James University Hospital, Leeds

Royal Brompton & Harefield NHS Foundation Trust, Royal Brompton Hospital, London

Wythenshawe Hospital, Manchester

Southampton General Hospital, Southampton

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY